Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Myeloid 1Dermatologic 1

Conditions

Hodgkin Disease 3Myelodysplastic Syndromes 2Lymphoma, Non-Hodgkin 2Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2Leukemia 2Hematologic Neoplasms 2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Multiple Myeloma 1Mastocytosis, Systemic 1Mastocytosis, Cutaneous 1Lymphoma 1Leukemia, Myeloid, Acute 1Leukemia, Hairy Cell 1Burkitt Lymphoma 1Blastic Plasmacytoid Dendritic Cell Neoplasm 1

Interventions

trolamine salicylate 1Diphenhydramine 1Blood Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Mastocytosis, Cutaneous × Diphenhydramine × Myeloid × Clear all
NCT04846348 2024-04-25

Topical Composition Therapy for the Treatment of Cutaneous Mastocytosis

Mayo Clinic

Phase 2 Terminated
1 enrolled 7 charts
DermatologicMyeloid

Mastocytosis, Cutaneous

Data powered by HemOnc (CC BY 4.0) Colophon âš¡